prazosin has been researched along with Kidney Diseases in 14 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The pharmacokinetics of doxazosin, following a single oral dose (1 mg) and chronic oral dosing (doubling doses up to a maximum of 16 mg day-1), were studied in 18 patients with mild to moderate hypertension and stable renal function varying from normal to severely impaired." | 7.68 | The pharmacokinetics of doxazosin in patients with hypertension and renal impairment. ( Dewhurst, AG; Honeywell, R; Oliver, RM; Renwick, AG; Upward, JW; Waller, DG, 1990) |
| "The pharmacokinetics of prazosin (Minipress) were studied in nine patients with NYHA Class 3 or 4 congestive heart failure and in five healthy controls." | 7.66 | Altered prazosin pharmacokinetics in congestive heart failure. ( Arnold, S; Baughman, RA; Benet, LZ; Chatterjee, K; Lin, ET; Williams, RL, 1980) |
| "Prazosin was used as an additional antihypertensive agent for treating 16 patients with hypertension and significant renal functional impairment." | 7.65 | Prazosin in the treatment of patients with hypertension and renal functional impairment. ( Bailey, RR; Little, PJ; Lynn, KL; Neale, TL, 1976) |
| " The pharmacokinetics of doxazosin, following a single oral dose (1 mg) and chronic oral dosing (doubling doses up to a maximum of 16 mg day-1), were studied in 18 patients with mild to moderate hypertension and stable renal function varying from normal to severely impaired." | 3.68 | The pharmacokinetics of doxazosin in patients with hypertension and renal impairment. ( Dewhurst, AG; Honeywell, R; Oliver, RM; Renwick, AG; Upward, JW; Waller, DG, 1990) |
| "The pharmacokinetics of prazosin (Minipress) were studied in nine patients with NYHA Class 3 or 4 congestive heart failure and in five healthy controls." | 3.66 | Altered prazosin pharmacokinetics in congestive heart failure. ( Arnold, S; Baughman, RA; Benet, LZ; Chatterjee, K; Lin, ET; Williams, RL, 1980) |
| "Prazosin was used as an additional antihypertensive agent for treating 16 patients with hypertension and significant renal functional impairment." | 3.65 | Prazosin in the treatment of patients with hypertension and renal functional impairment. ( Bailey, RR; Little, PJ; Lynn, KL; Neale, TL, 1976) |
| "To establish the effects of alpha-adrenoceptor blockade on dopamine-induced changes in renal hemodynamics and sodium excretion, dopamine dose-response curves were performed without and with pretreatment with the selective postsynaptic alpha 1-adrenoceptor antagonist prazosin in normal volunteers and in patients with renal disease and moderately impaired renal function." | 1.28 | The effects of alpha-adrenoceptor blockade on dopamine-induced renal vasodilation and natriuresis. ( Donker, AJ; Meijer, S; Reitsma, WD; Smit, AJ; Wesseling, H, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (71.43) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunnells, JC | 1 |
| Harter, HR | 1 |
| Delmez, JA | 1 |
| Kopstein, J | 1 |
| Garcez, DM | 1 |
| Baughman, RA | 1 |
| Arnold, S | 1 |
| Benet, LZ | 1 |
| Lin, ET | 1 |
| Chatterjee, K | 1 |
| Williams, RL | 1 |
| Vorburger, C | 1 |
| Brogden, RN | 1 |
| Heel, RC | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Bailey, RR | 1 |
| Lynn, KL | 1 |
| Neale, TL | 1 |
| Little, PJ | 1 |
| Rosenberg, ME | 1 |
| Hostetter, TH | 1 |
| Smit, AJ | 1 |
| Meijer, S | 1 |
| Wesseling, H | 1 |
| Donker, AJ | 2 |
| Reitsma, WD | 1 |
| Oliver, RM | 2 |
| Upward, JW | 1 |
| Dewhurst, AG | 1 |
| Honeywell, R | 1 |
| Renwick, AG | 1 |
| Waller, DG | 2 |
| Bartels, AC | 1 |
| de Vries, PM | 1 |
| Oe, LP | 1 |
| van Bronswÿk, H | 1 |
| Réveillaud, RJ | 1 |
| Fillastre, JP | 1 |
| Zech, P | 1 |
| Rambausek, M | 1 |
| Ritz, E | 1 |
| Mall, G | 1 |
| Mehls, O | 1 |
| Katus, H | 1 |
| Wood, M | 1 |
2 reviews available for prazosin and Kidney Diseases
| Article | Year |
|---|---|
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
Topics: Animals; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Eruptions; Dru | 1977 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Ca | 1986 |
2 trials available for prazosin and Kidney Diseases
| Article | Year |
|---|---|
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
Topics: Animals; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Eruptions; Dru | 1977 |
Comparative effects of antihypertensives on proteinuria: angiotensin-converting enzyme inhibitor versus alpha 1-antagonist.
Topics: Adult; Blood Pressure; Enalapril; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Disease | 1991 |
11 other studies available for prazosin and Kidney Diseases
| Article | Year |
|---|---|
Treating the patient with mild hypertension and renal insufficiency.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Diuretics; Humans; Hypertensio | 1983 |
[Effects of prazosin on the control of arterial pressure in hypertensive patients subjected to dialysis].
Topics: Blood Volume; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Prazosin; Quinazolin | 1980 |
[Prazosin in the treatment of arterial hypertension].
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; | 1980 |
Altered prazosin pharmacokinetics in congestive heart failure.
Topics: Adult; Aged; Female; Heart Failure; Humans; Kidney Diseases; Kinetics; Liver; Male; Metabolic Cleara | 1980 |
[Side effects of antihypertensive drugs].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Diabetes Me | 1978 |
Prazosin in the treatment of patients with hypertension and renal functional impairment.
Topics: Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Prazosin; Quinazolines | 1976 |
The effects of alpha-adrenoceptor blockade on dopamine-induced renal vasodilation and natriuresis.
Topics: Adult; Blood Pressure; Dopamine Antagonists; Female; Humans; Kidney; Kidney Diseases; Kidney Functio | 1991 |
The pharmacokinetics of doxazosin in patients with hypertension and renal impairment.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; F | 1990 |
Doxazosin in renal impairment.
Topics: Administration, Oral; Doxazosin; Drug Administration Schedule; Glomerular Filtration Rate; Half-Life | 1990 |
Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease | 1988 |
Myocardial hypertrophy in rats with renal insufficiency.
Topics: Adenosine Triphosphatases; Animals; Blood Pressure; Blood Transfusion; Calcium; Cardiomegaly; Hydral | 1985 |